Prepare smartly for NEET 2026 with Oswaal Books featuring updated syllabus coverage, solved papers, concept clarity and exam-focused practice for top ranks.

Designed for focused revision, Oswaal NEET resources include solved papers, concept guides and practice sets that support structured study and exam confidence.

Students can prepare for the CBSE Class 12 Biology Board Exam 2026 with this comprehensive guide. Access official syllabus, previous year papers, sample papers, and deleted topics from here.

Biogen Inc. (Nasdaq: BIIB) today announced that the Board of Directors has elected Dr. Maria C. Freire as Chair of the Board of Directors, effective immediately following the Company’s 2026 Annual ...

The ISC Class 12 English Language (Paper 1) Examination 2026 is scheduled to be conducted on 13th February 2026. As one of the core and compulsory subjects, English Language plays a crucial role in ...

CBSE Class 12 Biology last 10 days study plan for board exam 2026 with detailed day-wise revision strategy, daily timetable, high-weightage chapters, and exam-focused tips.

the Tiger's Nest Only four locked contentSecondary Prayer flags by the locked contentOnly heritage four schools locked contentby Bhutan Telecom the Tashi locked contentfour Choden schools in locked ...

While MP board class 11 exams are nearing, having a clear understanding of syllabus and marking scheme is essential and ...

Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveraging its first-in-class Flare platform, today announced that the U.S. Food and Drug Administration (FDA) has ...

With the Class 12 board examinations approaching, the CBSE Biology sample paper offers students a clear guide to the exam pattern, marking scheme and key topics ahead of the March 27 test. The Central ...

Intelligent Bio on Wednesday announced a new strategic manufacturing partnership with Syrma Johari MedTech Ltd. to support and scale the production of its Intelligent Fingerprinting Drug Screening ...

Chicago-based Amphix Bio has raised $12.5 million in seed funding to advance its experimental paralysis-reversing drug toward human trials, the Northwestern University spinout announced today. The ...